[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100611361":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":7,"locations":8,"responsibleParty":29,"collaborators":7,"id":31,"slug":32,"hasResults":33,"nctId":34,"briefTitle":35,"officialTitle":36,"acronym":37,"eligibilityCriteria":38,"healthyVolunteers":33,"sex":39,"minAge":40,"maxAge":7,"enrollmentInfo":41,"targetDuration":7,"studyType":44,"phases":7,"briefSummary":45,"conditions":46,"keywords":49,"overallStatus":11,"whyStopped":7,"lastUpdateSubmitDate":56,"lastUpdatePostDateStruct":57,"startDateStruct":60,"completionDateStruct":62,"leadSponsor":64,"locationsCount":65},{"fullName":5,"class":6},"Tam Anh Research Institute","OTHER",null,[9],{"facility":10,"status":11,"city":12,"state":13,"zip":14,"country":15,"countryCode":16,"cosmosGeoPoint":17,"geoPoint":22,"contacts":23},"Tam Anh TP. Ho Chi Minh General Hospital","RECRUITING","Ho Chi Minh City","Southern Vietnam","700000","Vietnam","VN",{"type":18,"coordinates":19},"Point",[20,21],106.62965,10.82302,{"lat":21,"lon":20},[24],{"name":25,"role":26,"phone":27,"phoneExt":7,"email":28},"Do Van Dung, Associate Professor","CONTACT","+84918382253","dungv@tamri.vn",{"type":30,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100611361","genotype-and-disease-burden-of-rsv-in-older-vietnamese-adults-rsv-respiratory-syncytial-virus--100611361",false,"NCT07239583","Genotype and Disease Burden of RSV in Older Vietnamese Adults (RSV: Respiratory Syncytial Virus )","A Description of the Proportion, Genotype Distribution of Respiratory Syncytial Virus and the Severity of Disease in Hospitalized Elderly in Vietnam","RSV-VN-Elderly","Inclusion Criteria:\n\nTo be enrolled in the study, participants must meet all inclusion criteria:\n\n1. Individuals ≥ 60 years old at the time of screening (calculated from the date of birth to the date of screening)\n2. ARI or exacerbation of cardiopulmonary diseases diagnosed at the time of admission. ARI or ARI-compatible symptoms were defined as either:\n\n   * New onset or increase from baseline of: nasal congestion, rhinorrhea, sore throat, hoarseness, cough, sputum production, dyspnea, wheezing, hypoxemia, or\n   * Admitting diagnosis suggestive of ARI (e.g., pneumonia, upper respiratory infection, bronchitis, influenza, cough, viral respiratory illness, respiratory distress, or respiratory failure), or\n   * Admitting diagnosis was the exacerbation of an underlying cardiac or pulmonary disease involving acute respiratory symptoms within the previous 2 weeks (e.g., congestive heart failure \\[CHF\\], chronic obstructive pulmonary disease \\[COPD\\], or asthma exacerbation).\n3. The participant agrees to voluntarily participate in this study.\n\nExclusion Criteria:\n\nTo be enrolled in the study, participants must have none of the exclusion criteria:\n\n1. Symptom onset \\> 6 days prior to screening date\n2. Acute symptoms confirmed to be unrelated to infection or as assessed by the investigator\n3. Admission to any hospital within the 30 days preceding the screening date\n4. Previously enrolled in the study in the last 45 days","ALL","60 Years",{"count":42,"type":43},1000,"ESTIMATED","OBSERVATIONAL","This observational, prospective, multicenter study aims to estimate the proportion of RSV infection in adults aged 60 years and older hospitalized due to acute respiratory infections or exacerbation of cardiopulmonary disease.",[47,48],"Respiratory Syncytial Virus Infection","Respiratory Syncytial Virus Infections",[50,51,52,53,54,55],"Respiratory Syncytial Virus (RSV)","Acute Respiratory Infection (ARI)","Metagenomic Sequencing (mNGS)","RSV Genotype","Disease Severity","Healthcare Resource Utilization","2025-11-16",{"date":58,"type":59},"2025-11-20","ACTUAL",{"date":61,"type":59},"2025-10-06",{"date":63,"type":43},"2027-03-30",{"name":5,"class":6},1]